1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Point of Care Diagnostics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Point of Care Diagnostics Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Prevalence of Infectious Diseases
- 5.1.2 Product Launches and Product Developments
- 5.1.3 Increasing Number of CLIA waived POC Tests
5.2 Market Opportunities
- 5.2.1 High Growth Opportunities in Emerging Markets
- 5.2.2 Increasing Number of Conferences and Events
5.3 Future Trends
- 5.3.1 Increasing Use of Home based POC Devices
5.4 Impact of Drivers and Restraints
6. North America Point of Care Diagnostics Market Regional Analysis
6.1 North America Point of Care Diagnostics Market Overview
6.2 North America Point of Care Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 North America Point of Care Diagnostics Market Forecast Analysis
7. North America Point of Care Diagnostics Market Analysis – by Product
7.1 Glucose Monitoring Products
- 7.1.1 Overview
- 7.1.2 Glucose Monitoring Products: North America Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Infectious Disease Testing Products
- 7.2.1 Overview
- 7.2.2 Infectious Disease Testing Products: North America Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cardiometabolic Testing Products
- 7.3.1 Overview
- 7.3.2 Cardiometabolic Testing Products: North America Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Pregnancy and Fertility Testing Products
- 7.4.1 Overview
- 7.4.2 Pregnancy and Fertility Testing Products: North America Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Coagulation Testing Products
- 7.5.1 Overview
- 7.5.2 Coagulation Testing Products: North America Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Tumor/Cancer Marker Testing Products
- 7.6.1 Overview
- 7.6.2 Tumor/Cancer Marker Testing Products: North America Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Cholesterol Testing Products
- 7.7.1 Overview
- 7.7.2 Cholesterol Testing Products: North America Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Urinalysis Testing Products
- 7.8.1 Overview
- 7.8.2 Urinalysis Testing Products: North America Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Hematology Testing Products
- 7.9.1 Overview
- 7.9.2 Hematology Testing Products: North America Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Other POC Products
- 7.10.1 Overview
- 7.10.2 Other POC Products: North America Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Point of Care Diagnostics Market Analysis – by Prescription Mode
8.1 Prescription-Based Testing
- 8.1.1 Overview
- 8.1.2 Prescription-Based Testing: North America Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 OTC Testing
- 8.2.1 Overview
- 8.2.2 OTC Testing: North America Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Point of Care Diagnostics Market Analysis – by End User
9.1 Professional Diagnostic Centers
- 9.1.1 Overview
- 9.1.2 OTC Testing: North America Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Home Care
- 9.2.1 Overview
- 9.2.2 OTC Testing: North America Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Research Laboratories
- 9.3.1 Overview
- 9.3.2 OTC Testing: North America Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Point of Care Diagnostics Market – North America Analysis
10.1 North America
- 10.1.1 North America Point of Care Diagnostics Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 North America Point of Care Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Point of Care Diagnostics Market Breakdown, by Product
- 10.1.1.1.2 US: North America Point of Care Diagnostics Market Breakdown, by Prescription Mode
- 10.1.1.1.3 US: North America Point of Care Diagnostics Market Breakdown, by End User
- 10.1.1.2 Canada:
North America Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Point of Care Diagnostics Market Breakdown, by Product
- 10.1.1.2.2 Canada: North America Point of Care Diagnostics Market Breakdown, by Prescription Mode
- 10.1.1.2.3 Canada: North America Point of Care Diagnostics Market Breakdown, by End User
- 10.1.1.3 Mexico :
North America Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Point of Care Diagnostics Market Breakdown, by Product
- 10.1.1.3.2 Mexico : North America Point of Care Diagnostics Market Breakdown, by Prescription Mode
- 10.1.1.3.3 Mexico : North America Point of Care Diagnostics Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Point of Care Diagnostics Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BD
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 bioMerieux SA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BIO-RAD LABORATORIES INC.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Danaher
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 F. HOFFMANN-LA ROCHE LTD.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Johnson and Johnson Services, Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Nova Biomedical
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Polymer Technology Systems, Inc. (PTS)
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Siemens AG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Point of Care Diagnostics Market
